Offering Materials. Each of the Company, its officers and directors has not distributed and will not distribute prior to the Closing Date any offering material, including any “free writing prospectus” (as defined in Rule 405 promulgated under the Securities Act), in connection with the offering and delivery of the Shares.
Appears in 22 contracts
Samples: Securities Purchase Agreement (Stins Coman Inc), Securities Purchase Agreement (Rit Technologies LTD), Securities Purchase Agreement (Stins Coman Inc)
Offering Materials. Each of the Company, its officers and directors The Company has not distributed and will not distribute prior to the Closing Date any offering material, including any “free writing prospectus” (as defined in Rule 405 promulgated under the Securities Act), in connection with the offering and delivery sale of the SharesSecurities.
Appears in 4 contracts
Samples: Preferred Stock and Warrant Purchase Agreement (Lime Energy Co.), Preferred Stock and Warrant Purchase Agreement (Lime Energy Co.), Preferred Stock and Warrant Purchase Agreement (Lime Energy Co.)
Offering Materials. Each of the Company, its directors and officers and directors has not distributed and will not distribute prior to the Closing Date any offering material, including any “free writing prospectus” (as defined in Rule 405 promulgated under the Securities Act), in connection with the offering and delivery sale of the New Shares.
Appears in 2 contracts
Samples: Standby Purchase Agreement (Biomimetic Therapeutics, Inc.), Standby Purchase Agreement (Biomimetic Therapeutics, Inc.)
Offering Materials. Each None of the Company, its officers and directors has not distributed and or will not distribute prior to the Closing Date any offering material, including any “free writing prospectus” (as defined in Rule 405 promulgated under the Securities Act), in connection with the offering and delivery sale of the SharesNotes.
Appears in 1 contract
Samples: Securities Purchase Agreement (Salon Media Group Inc)
Offering Materials. Each of the Company, its officers and directors The Company has not distributed and will not distribute prior to the any Closing Date any offering material, including any “free writing prospectus” (as defined in Rule 405 promulgated under the Securities Act), in connection with the offering and delivery sale of the SharesNotes other than the Transaction Documents, or any amendment or supplement thereto.
Appears in 1 contract
Offering Materials. Each of the Company, its directors and officers and directors has not distributed and will not distribute prior to the Closing Date any offering material, including any “free writing prospectusIssuer Free Writing Prospectus” (as defined in Rule 405 promulgated under the Securities 1933 Act), in connection with the offering and delivery sale of the SharesShares other than the Prospectus, and any amendment or supplement thereto.
Appears in 1 contract
Samples: Terms Agreement (BioLineRx Ltd.)
Offering Materials. Each of the Company, its officers and directors has not distributed and will not distribute prior to the Closing Date any offering material, including any “free writing prospectus” (as defined in Rule 405 promulgated under the Securities Act), in connection with the offering and delivery of the SharesWarrant.
Appears in 1 contract
Offering Materials. Each of the Company, its directors and officers and directors has not distributed and will not distribute prior to the Closing Date any offering material, including any “free writing prospectus” (as defined in Rule 405 promulgated under the Securities Act), in connection with the offering and delivery sale of the Shares.
Appears in 1 contract
Offering Materials. Each of the Company, its directors and officers and directors has not distributed and will not distribute prior to the Closing Date any offering material, including any “free writing prospectus” (as defined in Rule 405 promulgated under the Securities Act), in connection with the offering and delivery sale of the SharesOffered Securities other than the Prospectus, and any amendment or supplement thereto.
Appears in 1 contract
